Skip to main content

MoneyWorks4Me

Strides Pharma Science informs about ratings

22 Jan 2021 Evaluate

Strides Pharma Science has informed that India Ratings and Research (Ind-Ra) through its letter dated January 21, 2021 has upgraded company’s Long-Term Issuer Rating to ‘IND A+’ with a Stable Outlook from ‘IND A’ previously.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..